Your browser doesn't support javascript.
loading
Clinical and analytical validation of Ki-67 in 9069 patients from IBCSG VIII + IX, BIG1-98 and GeparTrio trial: systematic modulation of interobserver variance in a comprehensive in silico ring trial.
Denkert, Carsten; Budczies, Jan; Regan, Meredith M; Loibl, Sibylle; Dell'Orto, Patrizia; von Minckwitz, Gunter; Mastropasqua, Mauro G; Solbach, Christine; Thürlimann, Beat; Mehta, Keyur; Blohmer, Jens-Uwe; Colleoni, Marco; Müller, Volkmar; Klauschen, Frederick; Ataseven, Beyhan; Engels, Knut; Kammler, Roswitha; Pfitzner, Berit M; Dietel, Manfred; Fasching, Peter A; Viale, Giuseppe.
Afiliación
  • Denkert C; Institute of Pathology, Charité Universitätsmedizin Berlin, Berlin, Germany. Carsten.denkert@uni-marburg.de.
  • Budczies J; Institute of Pathology, Philipps-University Marburg, Marburg, Germany. Carsten.denkert@uni-marburg.de.
  • Regan MM; Institute of Pathology, Charité Universitätsmedizin Berlin, Berlin, Germany.
  • Loibl S; Institute of Pathology, University of Heidelberg, Heidelberg, Germany.
  • Dell'Orto P; International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • von Minckwitz G; German Breast Group, Neu-Isenburg, Germany.
  • Mastropasqua MG; International Breast Cancer Study Group Central Pathology Office, Division of Pathology and Laboratory Medicine, European Institute of Oncology, IRCCS, Milan, Italy.
  • Solbach C; German Breast Group, Neu-Isenburg, Germany.
  • Thürlimann B; International Breast Cancer Study Group Central Pathology Office, Division of Pathology and Laboratory Medicine, European Institute of Oncology, IRCCS, Milan, Italy.
  • Mehta K; Breast Center, University of Frankfurt, Frankfurt, Germany.
  • Blohmer JU; Breast Center, Kantonsspital, St. Gallen, St. Gallen, Switzerland.
  • Colleoni M; Swiss Group for Clinical Cancer Research (SAKK), St. Gallen, Switzerland.
  • Müller V; German Breast Group, Neu-Isenburg, Germany.
  • Klauschen F; Breast Center, Charité University Hospital, Berlin, Germany.
  • Ataseven B; Division of Medical Senology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
  • Engels K; International Breast Cancer Study Group, Milan, Italy.
  • Kammler R; Department of Gynecology, Universitätsklinikum Hamburg- Eppendorf, Hamburg, Germany.
  • Pfitzner BM; Institute of Pathology, Charité Universitätsmedizin Berlin, Berlin, Germany.
  • Dietel M; Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte, Essen, Germany.
  • Fasching PA; Department of Obstetrics and Gynecology, University Hospital, LMU, Munich, Germany.
  • Viale G; Zentrum für Pathologie, Zytologie und Molekularpathologie Neuss, Neuss, Germany.
Breast Cancer Res Treat ; 176(3): 557-568, 2019 Aug.
Article en En | MEDLINE | ID: mdl-31065870
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Biomarcadores de Tumor / Antígeno Ki-67 Tipo de estudio: Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Breast Cancer Res Treat Año: 2019 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Biomarcadores de Tumor / Antígeno Ki-67 Tipo de estudio: Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Breast Cancer Res Treat Año: 2019 Tipo del documento: Article País de afiliación: Alemania